| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Papadopoulos Stelios is a Director at EXELIXIS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 3 sells.
Estimated insider holdings value: $63.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2017 | EXEL Exelixis, Inc. | Director | Sell | 200,000 | $27.68 | $5,535,387.30 | -8.3% | |
| Mar 20, 2017 | EXEL Exelixis, Inc. | Director | Sale+OE | 10,000 | $21.66 | $216,600.00 | -0.8% | |
| Jul 27, 2015 | BIIB Biogen Inc. | Director | Buy | 10,000 | $304.88 | $3,048,775.00 | New |